Partner Frank Murray was quoted in a Bloomberg article, “Amazon’s $10 Billion Pentagon Challenge: Proving Trump Meddled,” about Amazon’s uphill battle to overturn a Pentagon decision to award a $10 billion cloud-computing contract to archrival Microsoft.
To help make its case, Murray said, Amazon could examine whether there were any differences between how the companies’ bids were evaluated by lower level technical staff and top Pentagon officials. If top officials overrode the recommendation of their technical staff, that could be a significant piece of evidence for Amazon. “The nuts and bolts of the case are going to be: how were the proposals evaluated? And were they reasonable?” he said.
(Subscription required)
To help make its case, Murray said, Amazon could examine whether there were any differences between how the companies’ bids were evaluated by lower level technical staff and top Pentagon officials. If top officials overrode the recommendation of their technical staff, that could be a significant piece of evidence for Amazon. “The nuts and bolts of the case are going to be: how were the proposals evaluated? And were they reasonable?” he said.
(Subscription required)
People
Related News
September 18, 2026
In the News
Patrick Daugherty Authors Article on Navigating Proposed SEC Crypto Asset Regulations
Foley & Lardner LLP partner Patrick Daugherty authored the Columbia Law School’s Blue Sky Blog article, “How to Advise Token Developers in Light of Proposed SEC Regulation Crypto Assets.”
September 17, 2026
In the News
Foley Featured in Law.com for Guiding Kontoor Brands in Sale of Lee®
Foley & Lardner LLP partner Bryan Schultz is featured for leading the Foley deal team which advised Kontoor Brands in the sale of its Lee® business in Law.com's “How the Deal Got Done” series.
September 15, 2026
In the News
David Rosen Shares Insights on FDA Efforts to Accelerate Human Clinical Trials
Foley & Lardner LLP partner David Rosen shared insights in the recent Law360 article, “FDA Seeks Applications For Project To Speed Up Human Trials,” on the FDA's pilot program pairing pharmaceutical companies with research institutions to accelerate human clinical trials.